Monte Rosa Therapeutics (GLUE) Institutional Ownership $5.05 -0.03 (-0.59%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$5.05 0.00 (0.00%) As of 03:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Monte Rosa Therapeutics (NASDAQ:GLUE)CurrentInstitutional OwnershipPercentage79.96%Number ofInstitutional Buyers(last 12 months)60TotalInstitutional Inflows(last 12 months)$105.03MNumber ofInstitutional Sellers(last 12 months)19TotalInstitutional Outflows(last 12 months)$24.75M Get GLUE Insider Trade Alerts Want to know when executives and insiders are buying or selling Monte Rosa Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data GLUE Institutional Buying and Selling by Quarter Monte Rosa Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/21/2025 Acadian Asset Management LLC16,385$76K0.0%N/A0.027% 5/16/2025 Goldman Sachs Group Inc.356,112$1.65M0.0%+122.7%0.579% 5/16/2025 Parkwood LLC708,000$3.29M0.3%+119.2%1.151% 5/16/2025 BVF Inc. IL5,660,132$26.26M1.1%+104.7%9.202% 5/16/2025 AQR Capital Management LLC229,536$1.07M0.0%N/A0.373% 5/15/2025 Trexquant Investment LP26,188$122K0.0%N/A0.043% 5/14/2025 AlphaQuest LLC27,251$126K0.0%-71.2%0.044% 5/14/2025 Wellington Management Group LLP187,731$871K0.0%-15.3%0.305% 5/13/2025 American Century Companies Inc.100,406$466K0.0%+30.7%0.163% 5/13/2025 Fox Run Management L.L.C.27,394$127K0.0%N/A0.045% Get the Latest News and Ratings for GLUE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Monte Rosa Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/12/2025 Nuveen LLC117,672$546K0.0%N/A0.191% 5/12/2025 Invesco Ltd.35,346$164K0.0%+175.1%0.057% 5/9/2025 Deutsche Bank AG24,850$115K0.0%-14.5%0.040% 5/9/2025 Charles Schwab Investment Management Inc.361,535$1.68M0.0%-2.4%0.588% 5/7/2025 Corton Capital Inc.29,348$136K0.4%-9.3%0.048% 5/7/2025 TD Asset Management Inc172,078$798K0.0%-21.8%0.280% 5/6/2025 Readystate Asset Management LP287,000$1.33M0.0%N/A0.467% 4/29/2025 Bank of New York Mellon Corp164,145$762K0.0%-3.6%0.267% 4/17/2025 Exchange Traded Concepts LLC18,928$88K0.0%-36.5%0.031% 3/24/2025 Wellington Management Group LLP221,741$1.54M0.0%+2.2%0.361% 2/17/2025 Vestal Point Capital LP425,000$2.95M0.2%-54.3%0.692% 2/17/2025 Squarepoint Ops LLC31,654$220K0.0%N/A0.052% 2/17/2025 Two Sigma Advisers LP26,000$180K0.0%N/A0.042% 2/17/2025 Two Sigma Investments LP278,785$1.94M0.0%+1,965.1%0.454% 2/17/2025 Suvretta Capital Management LLC1,563,798$10.85M0.4%-41.2%2.545% 2/17/2025 Sherbrooke Park Advisers LLC14,476$100K0.0%-27.6%0.024% 2/17/2025 Rafferty Asset Management LLC27,698$192K0.0%N/A0.045% 2/17/2025 ProShare Advisors LLC14,541$101K0.0%N/A0.024% 2/17/2025 Parkwood LLC323,000$2.24M0.2%-24.3%0.526% 2/17/2025 Millennium Management LLC46,370$322K0.0%+51.4%0.075% 2/17/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.24,701$172K0.0%+9.2%0.040% 2/17/2025 Focus Partners Wealth11,122$77K0.0%N/A0.018% 2/17/2025 Deutsche Bank AG29,064$202K0.0%+29.6%0.047% 2/17/2025 D. E. Shaw & Co. Inc.70,114$487K0.0%+283.3%0.114% 2/17/2025 Corton Capital Inc.32,366$225K0.1%N/A0.053% 2/17/2025 Cubist Systematic Strategies LLC92,818$644K0.0%N/A0.151% 2/17/2025 BVF Inc. IL2,764,471$19.19M0.7%N/A4.499% 2/17/2025 Bank of America Corp DE63,283$439K0.0%-13.8%0.103% 2/17/2025 BNP Paribas Financial Markets6,231$43K0.0%N/A0.010% 2/14/2025 Jane Street Group LLC14,581$101K0.0%-12.9%0.024% Trump Makes Major Crypto Announcement (Ad)Pay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift all boats equally. They're wrong. One project stands to benefit more than any other – not by accident, but seemingly by design. Click Here to Discover our #1 crypto for the Trump Presidency Bull Run now! 2/14/2025 Northern Trust Corp376,964$2.62M0.0%+5.1%0.614% 2/14/2025 Virtus ETF Advisers LLC9,126$63K0.0%N/A0.015% 2/14/2025 Price T Rowe Associates Inc. MD7,116,637$49.39M0.0%+7.8%11.583% 2/14/2025 Avoro Capital Advisors LLC4,345,000$30.15M0.4%-25.0%7.072% 2/14/2025 Tower Research Capital LLC TRC5,443$38K0.0%+192.8%0.009% 2/14/2025 Dimensional Fund Advisors LP144,811$1.01M0.0%+4.0%0.236% 2/13/2025 Marshall Wace LLP499,492$3.47M0.0%+187.3%0.813% 2/13/2025 Jump Financial LLC154,842$1.08M0.0%N/A0.252% 2/13/2025 Walleye Capital LLC39,647$275K0.0%N/A0.065% 2/13/2025 Barclays PLC70,741$491K0.0%+29.8%0.115% 2/13/2025 Renaissance Technologies LLC245,700$1.71M0.0%+12.3%0.400% 2/13/2025 Legal & General Group Plc3,597$25K0.0%-78.3%0.006% 2/13/2025 Invesco Ltd.12,847$89K0.0%N/A0.021% 2/13/2025 Wells Fargo & Company MN70,162$487K0.0%+215.9%0.114% 2/12/2025 Geode Capital Management LLC1,036,665$7.20M0.0%-0.8%1.687% 2/12/2025 Franklin Resources Inc.27,510$191K0.0%N/A0.045% 2/12/2025 Wellington Management Group LLP221,741$1.54M0.0%+2.2%0.361% 2/12/2025 Norges Bank445,868$3.09M0.0%N/A0.726% 2/12/2025 JPMorgan Chase & Co.24,094$167K0.0%+29.9%0.039% 2/12/2025 Versant Venture Management LLC5,652,922$39.23M45.2%N/A9.201% 2/11/2025 Vanguard Group Inc.3,156,354$21.91M0.0%+24.5%5.137% 2/11/2025 Sei Investments Co.17,236$120K0.0%N/A0.028% 2/11/2025 American Century Companies Inc.76,850$533K0.0%+27.3%0.125% 2/7/2025 AlphaQuest LLC94,633$657K0.1%N/A0.154% 2/6/2025 Charles Schwab Investment Management Inc.370,472$2.57M0.0%+6.9%0.603% 2/4/2025 Bank of New York Mellon Corp170,312$1.18M0.0%+2.2%0.277% 1/30/2025 Rhumbline Advisers61,791$429K0.0%+17.8%0.101% 1/24/2025 China Universal Asset Management Co. Ltd.13,027$90K0.0%N/A0.021% 1/17/2025 Janney Montgomery Scott LLC13,315$92K0.0%N/A0.022% 1/17/2025 SG Americas Securities LLC16,742$116K0.0%+60.7%0.027% 1/3/2025 GAMMA Investing LLC5,921$41K0.0%+10,665.5%0.010% 12/26/2024 JPMorgan Chase & Co.18,543$98K0.0%+38.2%0.030% 11/19/2024 Barclays PLC54,508$289K0.0%+395.1%0.089% 11/16/2024 Geode Capital Management LLC1,044,689$5.54M0.0%+23.3%1.700% 11/15/2024 Barclays PLC54,508$289K0.0%+395.1%0.089% 11/15/2024 Jane Street Group LLC16,741$89K0.0%-75.3%0.027% 11/15/2024 Wellington Management Group LLP217,001$1.15M0.0%+30.2%0.353% 11/15/2024 Sphera Funds Management LTD.118,103$626K0.1%-68.5%0.192% 11/15/2024 State Street Corp687,577$3.64M0.0%+8.1%1.119% 11/15/2024 Ikarian Capital LLC311,593$1.65M0.2%N/A0.507% 11/14/2024 Vestal Point Capital LP930,000$4.93M0.4%+4.5%1.514% 11/14/2024 UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC24,100$128K0.0%+54.5%0.039% 11/14/2024 MetLife Investment Management LLC24,855$132K0.0%N/A0.040% 11/13/2024 FMR LLC5,101,413$27.04M0.0%+0.1%8.303% 11/13/2024 The Manufacturers Life Insurance Company117,877$625K0.0%+14.8%0.192% 11/12/2024 Charles Schwab Investment Management Inc.346,498$1.84M0.0%+11.1%0.565% 11/9/2024 Intech Investment Management LLC14,457$77K0.0%N/A0.024% 11/6/2024 Cornercap Investment Counsel Inc.19,236$102K0.0%-54.1%0.031% 10/10/2024 Exchange Traded Concepts LLC29,798$158K0.0%-16.5%0.059% 10/3/2024 SG Americas Securities LLC10,419$55K0.0%N/A0.021% Elon’s NEXT Big IPO? (Ad)Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it takes for the entire thing to burn right up. It’s a NEW internet service poised to disrupt the entire $3.2 trillion telecom industry. But you may only have this chance if you act before December 31st, 2025.One that experts predict could be worth over $3.2 TRILLION globally by 2030.8/9/2024 Renaissance Technologies LLC254,714$953K0.0%+108.6%0.504% 8/9/2024 Dimensional Fund Advisors LP153,758$575K0.0%+111.6%0.304% 8/8/2024 Meeder Asset Management Inc.10,050$38K0.0%N/A0.020% 8/8/2024 American Century Companies Inc.49,410$185K0.0%+46.0%0.098% 8/6/2024 Acadian Asset Management LLC98,557$366K0.0%+77.4%0.195% 7/26/2024 Bank of New York Mellon Corp109,864$411K0.0%+16.9%0.218% 5/15/2024 Price T Rowe Associates Inc. MD5,096,787$35.93M0.0%+3.2%10.091% 5/14/2024 EntryPoint Capital LLC15,893$112K0.1%N/A0.031% 5/10/2024 Acadian Asset Management LLC55,548$390K0.0%+92.5%0.110% 5/10/2024 Vanguard Group Inc.1,635,829$11.53M0.0%+3.0%3.250% (Data available from 1/1/2016 forward) GLUE Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of GLUE shares? During the previous two years, 76 institutional investors and hedge funds held shares of Monte Rosa Therapeutics. The most heavily invested institutionals were Price T Rowe Associates Inc. MD ($49.39M), Versant Venture Management LLC ($39.23M), Avoro Capital Advisors LLC ($30.15M), FMR LLC ($27.04M), BVF Inc. IL ($26.26M), Vanguard Group Inc. ($21.91M), and Suvretta Capital Management LLC ($10.85M).Learn more on GLUE's institutional investors. What percentage of Monte Rosa Therapeutics stock is owned by institutional investors? 79.96% of Monte Rosa Therapeutics stock is owned by institutional investors. Learn more on GLUE's institutional investor holdings. Which institutional investors have been buying Monte Rosa Therapeutics stock? Of the 68 institutional investors that purchased Monte Rosa Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BVF Inc. IL ($5.66M), Versant Venture Management LLC ($5.65M), Price T Rowe Associates Inc. MD ($671.38K), Vanguard Group Inc. ($669.55K), Norges Bank ($445.87K), ExodusPoint Capital Management LP ($407.90K), and Parkwood LLC ($385K). How much institutional buying is happening at Monte Rosa Therapeutics? Institutional investors have bought a total of 17,829,692 shares in the last 24 months. This purchase volume represents approximately $111.40M in transactions. Which Monte Rosa Therapeutics major shareholders have been selling company stock? Of the 21 institutional investors that sold Monte Rosa Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Avoro Capital Advisors LLC ($1.45M), Suvretta Capital Management LLC ($1.10M), FMR LLC ($540.90K), Vestal Point Capital LP ($505K), Sphera Funds Management LTD. ($256.90K), Parkwood LLC ($103.62K), and TD Asset Management Inc ($72.25K). How much institutional selling is happening at Monte Rosa Therapeutics? Institutional investors have sold a total of 4,285,030 shares in the last 24 months. This volume of shares sold represents approximately $27.58M in transactions. Related Companies AUPH Major Shareholders ELVN Major Shareholders WVE Major Shareholders MLYS Major Shareholders RCUS Major Shareholders CVAC Major Shareholders SYRE Major Shareholders AKBA Major Shareholders PAHC Major Shareholders SNDX Major Shareholders This page (NASDAQ:GLUE) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Monte Rosa Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Monte Rosa Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy GLUE Stock Free GLUE Stock Alerts